Correlation Between Viking Therapeutics and Polydex Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Viking Therapeutics and Polydex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viking Therapeutics and Polydex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viking Therapeutics and Polydex Pharmaceuticals, you can compare the effects of market volatilities on Viking Therapeutics and Polydex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viking Therapeutics with a short position of Polydex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viking Therapeutics and Polydex Pharmaceuticals.
Diversification Opportunities for Viking Therapeutics and Polydex Pharmaceuticals
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Viking and Polydex is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and Polydex Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Polydex Pharmaceuticals and Viking Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viking Therapeutics are associated (or correlated) with Polydex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Polydex Pharmaceuticals has no effect on the direction of Viking Therapeutics i.e., Viking Therapeutics and Polydex Pharmaceuticals go up and down completely randomly.
Pair Corralation between Viking Therapeutics and Polydex Pharmaceuticals
Given the investment horizon of 90 days Viking Therapeutics is expected to generate 4.26 times more return on investment than Polydex Pharmaceuticals. However, Viking Therapeutics is 4.26 times more volatile than Polydex Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Polydex Pharmaceuticals is currently generating about 0.09 per unit of risk. If you would invest 2,479 in Viking Therapeutics on August 31, 2024 and sell it today you would earn a total of 2,815 from holding Viking Therapeutics or generate 113.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 8.56% |
| Values | Daily Returns |
Viking Therapeutics vs. Polydex Pharmaceuticals
Performance |
| Timeline |
| Viking Therapeutics |
| Polydex Pharmaceuticals |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Viking Therapeutics and Polydex Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Viking Therapeutics and Polydex Pharmaceuticals
The main advantage of trading using opposite Viking Therapeutics and Polydex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viking Therapeutics position performs unexpectedly, Polydex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Polydex Pharmaceuticals will offset losses from the drop in Polydex Pharmaceuticals' long position.| Viking Therapeutics vs. Cue Biopharma | Viking Therapeutics vs. Eliem Therapeutics | Viking Therapeutics vs. Inhibrx | Viking Therapeutics vs. Molecular Partners AG |
| Polydex Pharmaceuticals vs. ImmuCell | Polydex Pharmaceuticals vs. Senstar Technologies | Polydex Pharmaceuticals vs. Natural Alternatives International | Polydex Pharmaceuticals vs. Paragon Technologies |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |